Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial

NCT05554094 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT05554094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05554094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial
Lead sponsor
Ohio State University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 1, 2023
Completion date
July 31, 2026
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mental disorder, ptsd, stress disorders, post-traumatic, stress disorders, traumatic, trauma and stressor related disorders